resTORbio to Host its 2020 Annual Shareholder Meeting Virtually on June 3, 2020
April 30 2020 - 4:01PM
resTORbio, Inc. (Nasdaq: TORC) today announced that due to the
public health impact of the coronavirus pandemic and to prioritize
the health and well-being of its employees, stockholders, and other
meeting participants, the company has changed the date and format
of its 2020 Annual Meeting of Stockholders (the “Annual Meeting”).
The Annual Meeting will now be held at 1:00 p.m. (ET) on Wednesday,
June 3, 2020 by means of a virtual meeting format only instead of
the date and location previously disclosed in resTORbio’s proxy
materials filed with the Securities and Exchange Commission on
March 27, 2020. Shareholders will not be able to attend the 2020
annual meeting in person.
Shareholders at the close of business on the record date, March
16, 2020, are entitled to attend the 2020 annual meeting. To attend
and participate in the Annual Meeting, shareholders must register
in advance at http://viewproxy.com/restorbio/2020 (the “Meeting
Registration Website”) prior to the deadline of 11:59 p.m. ET on
June 1, 2020. Upon completing registration, eligible participants
will receive further instructions via email, including unique links
that will allow such eligible participants to access the meeting.
Eligible participants who have difficulty accessing the virtual
meeting or the Meeting Registration Website may call the technical
support number provided.
Shareholders of record may vote by internet at
www.proxyvote.com, by telephone using a touch-tone telephone at
1-800-690-6903 or by marking, signing and dating the proxy card and
returning it in the postage-paid envelope provided to Vote
Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717 by
11:59 p.m. ET on June 2, 2020.
Please note that the proxy card and voting instruction form
included with previously distributed proxy materials will not be
updated to reflect the change from an in-person meeting to a
virtual-only meeting and may be used to vote shares in connection
with the annual meeting. Whether or not shareholders plan to attend
the virtual-only annual meeting, resTORbio urges shareholders to
vote and submit their proxies in advance of the meeting by one of
the methods described in the proxy materials.
About resTORbio resTORbio, Inc. is a
clinical-stage biopharmaceutical company developing innovative
medicines that target the biology of aging to treat aging-related
diseases. resTORbio’s lead program selectively inhibits TORC1, an
evolutionarily conserved pathway that contributes to the decline in
function of aging organ systems, including neurologic function.
Learn more about resTORbio, Inc. at www.resTORbio.com.
Investor ContactJanhavi MohiteStern Investor
Relations, Inc.212-362-1200janhavi.mohite@sternir.com
Media ContactLauren
ArnoldMacDougall617-694-5387larnold@macbiocom.com
resTORbio (NASDAQ:TORC)
Historical Stock Chart
From Mar 2024 to Apr 2024
resTORbio (NASDAQ:TORC)
Historical Stock Chart
From Apr 2023 to Apr 2024